| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 96.38B | 95.41B | 94.80B | 86.52B | 84.13B | 80.71B |
| Gross Profit | 12.67B | 13.19B | 11.81B | 9.68B | 8.21B | 11.15B |
| EBITDA | 10.99B | 11.38B | 10.60B | 8.75B | 7.81B | 10.60B |
| Net Income | 3.57B | 4.37B | 3.61B | 4.59B | 4.13B | 5.25B |
Balance Sheet | ||||||
| Total Assets | 137.66B | 141.31B | 140.77B | 134.27B | 124.15B | 126.82B |
| Cash, Cash Equivalents and Short-Term Investments | 8.90B | 7.81B | 11.38B | 13.43B | 10.30B | 12.06B |
| Total Debt | 28.75B | 26.49B | 29.60B | 27.21B | 24.64B | 24.79B |
| Total Liabilities | 51.90B | 51.20B | 54.93B | 50.34B | 45.57B | 48.25B |
| Stockholders Equity | 79.26B | 83.46B | 78.68B | 77.01B | 72.23B | 72.29B |
Cash Flow | ||||||
| Free Cash Flow | 594.00M | 1.66B | -1.13B | 5.09B | -2.15B | 2.24B |
| Operating Cash Flow | 2.49B | 9.89B | 8.77B | 11.40B | 2.58B | 9.58B |
| Investing Cash Flow | -2.66B | -7.92B | -9.37B | -6.10B | -1.15B | -4.70B |
| Financing Cash Flow | -1.53B | -5.49B | -1.50B | -2.58B | -3.18B | -6.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥62.03B | 12.82 | ― | 2.67% | 0.65% | 22.48% | |
67 Neutral | ¥161.40B | 12.48 | 3.57% | 1.31% | 0.86% | 158.75% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥798.99B | 13.87 | 2.55% | 3.51% | 0.67% | 31.73% | |
57 Neutral | ¥135.45B | 20.97 | 3.97% | 2.71% | -5.88% | -52.79% | |
55 Neutral | ¥45.96B | 19.03 | -0.13% | 2.31% | -10.51% | -56.26% | |
49 Neutral | ¥156.57B | 19.04 | 1.66% | 1.53% | -1.57% | ― |